Skip to content

Twist Bioscience Corporation TWST Restructuring Charges

Discontinued — last reported Q4 '25

Restructuring Charges at other companies

International Flavors & Fragrances logo
International Flavors & FragrancesIFF
$6M-64.7%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Revvity logo
RevvityRVTY

Segments

By segment

See full
Reportable Segment$0

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCosts.

The official record: Twist Bioscience Corporation’s 10-K, filed November 17, 2025, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's restructuring charges?
Twist Bioscience Corporation (TWST) reported restructuring charges of $0 in Q3 2025.
What does restructuring charges mean?
One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.